A company born out of ground-breaking research at the university of warwick has raised almost £3 million of to develop a testosterone patch for people suffering from low libido and reduced zest for life

due to the menopause. Medherant, founded by university of warwick’s, professor david haddleton, is aiming to begin clinical trials of this pioneering treatment in autumn 2023. Medherant is ultimately aiming to get approval for clinical use, subject to a successful trial. Assuming trials go well, this would be the only testosterone replacement patch available globally and introduced first in the uk. Whilst oestrogen and progesterone hrt patches are available, there is currently no transdermal delivery patch available for testosterone delivery for women suffering from adverse symptoms from the menopause.

Increase Testosterone the Natural Way - VigRX Official Store https://t.co/pHtRIlVtqe

— VigRX Official Store - VigRX Plus, SemenHance (@vigrxstore) testosterone boosters April 10, 2023